Mike Papantonio discusses the impact of Pharmacy Benefit Managers (PBMs) on the healthcare system, mainly focusing on the high costs of medications like insulin.
He highlights the lack of transparency and the manipulative practices of PBMs, which include backdoor deals and kickbacks disguised as rebates and administrative fees. These practices significantly inflate drug prices, making essential medications unaffordable for many.
PMBs and the soaring price of insulin are central to Papantonio's new novel, "The Middleman."
